Dong Wha Pharm signs exclusive sales agreement of Plavix to clinics in Korea with Sanofi-Aventis

Published: 2017-05-02 14:03:14

Updated: 2017-05-02 14:03:14

Dong Wha Pharm(CEO Ji-Hoon Sohn) signed an exclusive distribution and sales agreement of Plavix(generic name: clopidogrel bisulfate), an anti-platelet drug, to Korean clinics with Sanofi.Aventis Korea(CEO Kyung-Eun Bae). Under the agreement, Dong Wha Pharm has taken charge in sales and marketing activities for Plavix on all the clinics in Korea since April 2017.

Launched in Korea in 1999, Plav...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.